The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies.

Time: 8:00 AM – 5:00 PM

Venue details: Hyatt Regency Boston Harbor, 101 Harborside Drive, Boston, Massachusetts, 02128, United States

Prices: USD 2199.00 – USD 5197.00

Speakers: Ross Jeggo, Head of Neurology Research, Biogen, Jessica Wu, Scientific Director, Biogen, Achim Kless PhD, Senior Director, Discovery Neuroscience Research, Neuroscience Genetics, Eli Lilly and Co., and more